Form 13-F position report

UNITEDHEALTH GROUP INC

Reported by BARROW HANLEY MEWHINNEY & STRAUSS LLC

UNH CUSIP 91324P102 Manager CIK 0000313028

Reported 1,446,988 shares, down 15,179 (1.0%) from the prior quarter.

Reported value -12.6%; share count -1.0% vs. the prior quarter.

Reduced
% of reported 13F value 1.69% This manager · Q3 2026
Shares 1,446,988 Quarter-end amount reported
Reported value $531,160,355 Fair value at quarter end
Consecutive quarters held 54 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 635749000
2022-03-31 616680000
2022-06-30 603358000
2022-09-30 576716000
2022-12-31 576887268
2023-03-31 472269112
2023-06-30 453237753
2023-09-30 452934549
2023-12-31 441919444
2024-03-31 335275505
2024-06-30 356922001
2024-09-30 406495847
2024-12-31 362523051
2025-03-31 537939958
2025-06-30 312788297
2025-09-30 347605223
2025-12-31 427250149
2026-03-31 360504892
2026-06-30 607720471
2026-09-30 531160355

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for UNITEDHEALTH GROUP INC held by BARROW HANLEY MEWHINNEY & STRAUSS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 1,446,988 -15,179 (-1.0%) 1.69% $531,160,355 2026-11-12
Q2 2026 Added 1,462,167 +129,875 (9.7%) 1.84% $607,720,471 2026-08-12
Q1 2026 Added 1,332,292 +38,026 (2.9%) 1.18% $360,504,892 2026-05-13
Q4 2025 Added 1,294,266 +287,590 (28.6%) 1.42% $427,250,149 2026-02-11
Q3 2025 Added 1,006,676 +4,053 (0.4%) 1.11% $347,605,223 2025-11-13
Q2 2025 Reduced 1,002,623 -24,470 (-2.4%) 1.05% $312,788,297 2025-08-12
Q1 2025 Added 1,027,093 +310,446 (43.3%) 1.95% $537,939,958 2025-05-12
Q4 2024 Added 716,647 +21,402 (3.1%) 1.24% $362,523,051 2025-02-12
Q3 2024 Reduced 695,245 -5,619 (-0.8%) 1.33% $406,495,847 2024-11-13
Q2 2024 Added 700,864 +23,129 (3.4%) 1.22% $356,922,001 2024-08-13
Q1 2024 Reduced 677,735 -161,666 (-19.3%) 1.13% $335,275,505 2024-05-13
Q4 2023 Reduced 839,401 -58,940 (-6.6%) 1.55% $441,919,444 2024-02-12
Q3 2023 Reduced 898,341 -44,647 (-4.7%) 1.73% $452,934,549 2023-11-13
Q2 2023 Reduced 942,988 -56,333 (-5.6%) 1.69% $453,237,753 2023-08-10
Q1 2023 Reduced 999,321 -88,776 (-8.2%) 1.83% $472,269,112 2023-05-11
Q4 2022 Reduced 1,088,097 -53,825 (-4.7%) 2.17% $576,887,268 2023-02-14
Q3 2022 Reduced 1,141,922 -32,771 (-2.8%) 2.36% $576,716,000 2022-11-10
Q2 2022 Reduced 1,174,693 -34,556 (-2.9%) 2.28% $603,358,000 2022-08-11
Q1 2022 Reduced 1,209,249 -56,831 (-4.5%) 2.01% $616,680,000 2022-05-13
Q4 2021 Reduced 1,266,080 -8,580 (-0.7%) 2.01% $635,749,000 2022-02-10
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

3529 managers reported UNITEDHEALTH GROUP INC for Q3 2026.

Managers reporting UNITEDHEALTH GROUP INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 77,211,952 +348,891 0.42% $28,342,963,233 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 58,757,463 -554,062 0.45% $21,568,689,518 3 qtrs
STATE STREET CORPORATION Added 45,703,591 +70,324 0.49% $16,776,874,184 54 qtrs
FMR LLC Added 31,060,207 +3,067,212 0.49% $11,401,580,315 54 qtrs
Capital World Investors Reduced 28,480,541 -1,407,391 1.27% $10,455,486,517 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 24,577,840 +94,606 0.41% $9,022,033,507 3 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 22,173,963 -979,850 0.82% $8,139,620,000 54 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 20,745,390 -1,006,547 0.39% $7,580,119,656 54 qtrs
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Added 20,350,294 +519,706 0.96% $7,471,288,717 54 qtrs
JPMorgan Chase & Co Reduced 17,611,429 -2,634,618 0.36% $6,603,229,944 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 12, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,066,465
Shared
0
None
380,523

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.